Drug intelligence / Profile preview

3-methylcholanthrene

Development stage
Discontinued
Modality
Small Molecules
Administration
Experimental; Typically Administered By Injection (subcutaneous, Intraperitoneal) In Animal Models[2][9]
01

Overview

3-methylcholanthrene is a highly carcinogenic polycyclic aromatic hydrocarbon (PAH) used primarily in laboratory research to induce tumors and study chemical carcinogenesis[1][2][9]. It is an alkylated derivative of benz[a]anthracene with a pentacyclic ring structure and has similar properties to other PAHs used in experimental oncology. 3-methylcholanthrene is a potent aryl hydrocarbon receptor (AhR) agonist, leading to altered gene expression and the induction of cytochrome P450 enzymes[2]. Its carcinogenic action results from the induction of DNA mutations and tumor initiation, and it is commonly used to induce fibrosarcomas and skin carcinomas in animal models[1][2][9]. There are no therapeutic or pharmaceutical uses in humans; its application is strictly experimental due to its toxicity and carcinogenicity. It is not developed or manufactured as a medicine, but as a chemical reagent for research.

Other names
methylcholanthrene20-methylcholanthrenebenz[j]aceanthrylene 1,2-dihydro-3-methylcholanthrene 3-methylcholanthrene3-methylcholanthrene-3-methyl3-methyl-1,2-dihydrocyclopenta[ij]tetraphenecholanthrene 20(3)-methylMC
02

Targets

AHR (Aryl hydrocarbon receptor)

Beyond the preview

Go deeper on 3-methylcholanthrene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-methylcholanthrene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call